FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 24, 2017

Study Completion Date

June 14, 2017

Conditions
Anemia
Interventions
DRUG

FG-4592

DRUG

Epoetin Alfa

Trial Locations (31)

200025

Rui Jin Hospital Shanghai Jiao Tong University School of Medication, Shanghai

200040

Huashan Hospital of Fudan University, Shanghai

Unknown

The Second Hospital of Anhui Medical University, Hefei

301 Hospital, Beijing

Peking Union Medical College Hospital, Beijing

Peking University First Hospital, Beijing

Peking University Third Hospital, Beijing

Pekingg University, People's Hospital, Beijing

The First Affiliated hospital of Third Military Medical University (Southwest Hospital), Chongqing

Lan Zhou University Second Hospital, Lanzhou

Guangdong General Hospital, Guangzhou

Nanfang Hospital, Southern Medical University, Guangzhou

Shenzhen People's Hospital, Shenzhen

The First Affiliated hospital of Guangxi Medical University, Nanning

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

The Second Xiangya Hospital of Central South University, Changsha

The First Hospital of Baotou Medical School of Inner Mongolia University of Science and Technology, Baotou

Jiangsu Province Hospital, Nanjing

Nanjing General Hospital of Nanjing Military Command, Nanjing

Zhongda Hospital Southeast University, Nanjing

The First Affiliated Hospital of Nanchang University, Nanchang

The First Affiliated Hospital of Dalian Medical University, Dalian

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Shandong Provincial Hospital, Jinan

Shanghai Changzheng Hospital, Shanghai

Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medication, Shanghai

The Second Hospital of Shanxi Medical University, Taiyuan

West China Hospital, Sichuan Universtiy, Chengdu

Tianjin Medical University General Hospital, Tianjin

The First Affiliated Hospital, Zhejiang University, Hangzhou

Ningbo No.2 Hospital, Ningbo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

FibroGen

INDUSTRY

NCT02652806 - FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter